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Keratinocyte stem cells are present in the murine
epidermis, based on both in vitro and in vivo evid-
ence, and better characterization of these cells
remains an active goal. Because keratinocyte stem
cells are believed to cycle slowly, a good method for
identi®cation is based on their ability to retain
nucleoside analog, such as bromodeoxyuridine.
Adult stem cells have been identi®ed in other tissues,
including hematopoietic, neural, and skeletal muscle,
and stem cell surface markers have been character-
ized. We wanted to determine if cell-surface markers
present on both hematopoietic and skeletal muscle
stem cells (CD34, Sca-1, and Flk-1) were also present
on keratinocyte stem cells, and could be used to
identify them. The cell-surface expression of cells
that retained bromodeoxyuridine label for at least
21 d was compared with that of nonlabel-retaining
cells. Double-labeling for ¯ow cytometric analysis
was employed, and label-retaining cells were found
to lack expression of the tested markers. b1 integrin
levels were also evaluated, and although high expres-
sion was found on label-retaining cells, it was not
speci®c for these cells. Key words: differentiation/
mouse/skin/stem cells. J Invest Dermatol 117:943±948,
2001
T
he epidermis is a rapidly self-regenerating epithelial
tissue, and both rodent and human epidermis have
been shown to consist of discrete units of proliferation
in which cell production activity is balanced with cell
loss (Mackenzie, 1969; Christophers, 1971; Allen and
Potten, 1974; Mackenzie et al, 1981; Potten, 1981). A stem cell
theory for squamous epithelia was proposed that holds that a
proliferative hierarchy exists at the basal layer, analogous to that of
the hematopoietic system (Potten, 1974; Lajtha, 1979; Lavker and
Sun, 1982). The basal layer is believed to consist of distinct
subpopulations: stem cells that are undifferentiated, slow-cycling
cells with unlimited regenerative potential; transit amplifying cells
that undergo a more rapid but ®nite number of cell divisions; and
postmitotic, early differentiating cells.
Several lines of evidence support the existence of epidermal stem
cells. Following g-irradiation (depletion) of epidermis, a small
percentage of radioresistant cells are capable of repopulating the
epidermis (Potten and Hendry, 1973). Keratinocytes transduced
with retroviral vectors expressing an indicator gene (b-galactosid-
ase) and then grafted onto immunocompromised mice have also
demonstrated long-term expression (40 wk postgraft period)
(Kolodka et al, 1998). In addition, individual keratinocytes show
heterogeneity with regard to colony-forming ability when grown
in culture, and clones have been classi®ed into three types:
paraclones, meroclones, and holoclones (Barrandon and Green,
1987). Holoclones, which have the greatest proliferative potential,
are believed to represent colonies derived from epidermal stem
cells.
Further evidence for the existence of keratinocyte stem cells
comes from in vivo studies that have demonstrated variation in the
rate of cell cycling of epidermal cells. Experiments in which young
mice were labeled with tritiated thymidine or BrdU revealed that a
small percentage of basal keratinocytes retained nuclear label after
30 d and for up to 240 d (Bickenbach, 1981; Morris et al, 1985;
Bickenbach et al, 1986; Cotsarelis et al, 1990; Bickenbach and
Chism, 1998). These slowly cycling cells are referred to as label-
retaining cells (LRC) and are thought to represent the epidermal
stem cell subpopulation, which are quiescent or slowly dividing
in vivo. LRC were capable of forming colonies in vitro (Morris and
Potten, 1994) and were found to be undifferentiated, based on the
expression of known differentiation markers (cytokeratins and
bullous pemphigoid antigen) (Mackenzie et al, 1989). Label
retention is presently one of the best available indicators of
epidermal stem cells.
Prior investigations have attempted to characterize epidermal
stem cells. Differing expression levels of adhesion molecules have
been investigated (reviewed by Watt, 1998). Mouse keratinocytes
rapidly adhering to a variety of substrates were enriched for LRC
(Bickenbach and Chism, 1998). Keratinocytes with high levels of
b1 integrin expression had high colony forming ef®ciency (Jones
and Watt, 1993), suggesting that high expression is a characteristic
feature of epidermal stem cells. b1 integrin expression, however, is
not unique to stem cells as 40% of the basal cell population showed
bright staining for b1 integrin when analyzed by quantitative
confocal microscopy (Jones et al, 1995). Human keratinocytes with
high levels of a6 integrin expression and low CD71 (transferrin
receptor) expression were found to have the greatest long-term
proliferative capacity amongst basal cells in culture, and cell-cycle
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kinetic analysis indicated that they were slow-cycling in vivo,
consistent with properties expected of epidermal stem cells (Li et al,
1998; Kaur and Li, 2000). A study of murine epidermal cells taken
from BrdU-labeled mice and isolated by ¯uorescence-activated cell
sorting (FACS) indicated that 70% of LRC were in the high a6
integrin/low CD71 group (Tani et al, 2000).
Markers have also been sought for hair follicle stem cells, which
reside anatomically in the bulge region of the follicle. Labeling
studies with tritiated thymidine in mice (Cotsarelis et al, 1990;
Taylor et al, 2000) and BrdU in a human skin/scid mouse model
(Lyle et al, 1998) have demonstrated that LRC localize to the bulge.
Immunostaining for cytokeratin 15 (Lyle et al, 1999) and
cytokeratin 19 (Michel et al, 1996) also localized to the follicular
bulge in human skin. Staining for cytokeratin 15 was observed in all
basal cells in humans (Waseem et al, 1999) and sheep (Whitbread
and Powell, 1998), however, and staining for cytokeratin 19
extended beyond the follicular bulge region in humans (Lyle et al,
1998). It has been shown that in the skin of normal newborn mice,
and adult mice in response to a penetrating wound, follicular
keratinocytes migrate to the epidermis (Taylor et al, 2000). This
suggests the possibility that follicular and epidermal stem cells are
not necessarily distinct populations but may represent progenitor
cells existing in a single hierarchy.
Recently, the surprisingly multipotent nature of stem cells in
various organ systems has been demonstrated. For example, bone
marrow contains human mesenchymal stem cells, which can be
induced in culture to differentiate to adipocytic, chondrocytic, or
osteocytic lineages (Pittenger et al, 1999); rat and human
mesenchymal stem cells also have the ability to differentiate into
neurons in culture (Woodbury et al, 2000). The plasticity of stem
cells has also been illustrated by animal transplantation studies in
which donor and recipient strains differ, so that the cell of origin
(i.e., donor versus recipient) can be determined. Using this
experimental method, it was shown that injected murine neural
stem cells (Bjornson et al, 1999) and skeletal muscle stem cells
(Gussoni et al, 1999; Jackson et al, 1999) were able to repopulate the
hematopoietic compartment in mice that underwent bone marrow
ablation. In addition, following bone marrow transplantation,
donor-derived cells were found in murine muscle (Ferrari et al,
1998; Gussoni et al, 1999) and neural cells of the brain (Eglitis and
Mezey, 1997; Brazelton et al, 2000; Mezey et al, 2000) as well as
canine vascular endothelial cells (Shi et al, 1998). Bone marrow
transplantation studies also demonstrated that puri®ed murine
hematopoietic stem cells can differentiate into epithelial cells of the
skin, lung, and gastrointestinal tract (Krause et al, 2001), as well as
the liver (Lagasse et al, 2000; Krause et al, 2001).
Interestingly, murine hematopoietic and skeletal muscle stem
cells, isolated by their common ability to ef¯ux the vital dye
Hoechst 33342, have also been found to share the marker Sca-1
(Gussoni et al, 1999; Jackson et al, 1999). Another study in which
skeletal muscle stem cells from the mdx mouse model for Duchenne
muscular dystrophy were isolated by culture techniques found that
they shared the hematopoietic markers CD34 and Flk-1, in
addition to Sca-1 (Lee et al, 2000). This led us to postulate that
these markers might be similarly shared on epidermal stem cells.
We investigated if these markers were expressed on LRC in the
mouse epidermis, and thus might represent a potential means of
isolating and better understanding the biology of epidermal stem
cells.
MATERIALS AND METHODS
BrdU labeling BALB/C mice were labeled during the second week of
life. Mice received intraperitoneal injections twice a day for four
consecutive days with 0.25 mg of BrdU (Sigma, St. Louis, MO) diluted
in 0.1 ml of phosphate-buffered saline (PBS). Mice were then allowed to
grow without further labeling.
Isolation of keratinocytes Following a different chase period up to
28 d, truncal skin specimens were obtained and the subcutaneous fat was
removed. Specimens were incubated overnight at 4°C in a 1:1 mixture
of dispase (50 caseinolytic units per ml, Collaborative Biomedical
Products, Bedford, MA) and Hanks' balanced salt solution. Skin samples
were transferred to 0.25% trypsin (Gibco/BRL, Paisley, U.K.) for
60 min at 37°C. Epidermal sheets were then removed and dissociated
into single cells by pipetting. Completeness of epidermal removal was
assessed by hematoxylin and eosin staining.
Monoclonal antibodies The following purchased monoclonal
antibodies were used for ¯ow cytometric analysis: anti-BrdU antibodies
[clone MOPC-21, mouse IgG1 ¯uorescein isothiocyanate (FITC) or
phycoerythrin (PE) conjugated, or BrdU Flow Kit, Pharmingen, San
Diego, CA]; anti-CD34 (clone RAM34, rat IgG2a-FITC, Pharmingen);
anti-Sca-1 (clone D7, rat IgG2a-FITC, Pharmingen); anti-Flk1 (clone
Avas 12a1, rat IgG2a-PE, Pharmingen); anti-CD29 (integrin b1 chain)
(clone Ha2/5, Armenian hamster IgM-FITC, Pharmingen); antipan-
cytokeratin (clone C-11, mouse IgG1-FITC, Sigma). The appropriate
isotype-matched negative control antibodies were utilized for FACS
studies in each experiment.
Immunohistochemistry Anti-BrdU-peroxidase, Fab fragments (clone
BMG-6H8, Boehringer, Mannheim, Germany) were employed for
immunohistochemistry. BrdU staining was performed on 70% ethanol-
®xed, paraf®n-embedded sections of truncal skin. Paraf®n-embedded
sections were dewaxed and rehydrated. Sections were treated with 4 M
HCl for 15 min at room temperature, neutralized with 0.1 M sodium
borate for 5 min, and washed three times in PBS with 10% fetal bovine
serum (5 min each). This was followed by incubation with anti-BrdU-
peroxidase Fab fragments (1:50 dilution in PBS with 1% bovine serum
albumin) at room temperature for 1 h. Staining was then performed with
a peroxidase detection kit (Vector VIP Substrate Kit, Vector
Laboratories, Burlingame, CA).
Immuno¯uorescence staining and FACS of keratinocytes Cells
were processed for BrdU staining and FACS analysis as described by
Pharmingen either with ®xation in 70% ethanol for 20 min, denaturing
with 2 M HCl for 20 min, and neutralization with 0.1 M sodium borate
for 5 min at room temperature or using the BrdU Flow Kit
(Pharmingen), which employs paraformaldehyde ®xation and then
DNase treatment (30 mg per 106 cells) for 1 h at 37°C. Cells were
double-stained with separate 1 h incubations at room temperature.
Compensation settings were established using positive control antibodies
to H-2Dd (clone 34-5-8S, mouse IgG2a-FITC and mouse IgG2a-PE,
Pharmingen). Following antibody staining and washing with PBS with
0.5% bovine serum albumin, cells were resuspended in 5% fetal bovine
serum in PBS and washed twice, and ¯ow cytometric analysis was
performed using FACscan or FACSCalibur and CellQuest software
(Becton Dickinson). For each experiment, a minimum of 10,000 cells
were counted after gating on forward and side scatter to exclude debris.
RESULTS
Identi®cation of LRC by immunohistochemistry Immuno-
histochemistry was conducted to determine if a subset of epidermal
and hair follicle cells retained BrdU label 3±4 wk after
intraperitoneal labeling was completed and to con®rm that LRC
were present in the expected anatomical location. Immediately
after the completion of labeling in our mice, most basal cells
showed staining for BrdU (Fig 1a). Marked nuclear staining was
apparent in a linear pattern along the basal layer of the epidermis, as
well as in hair follicles and numerous ®broblasts in the dermis. At
1 wk, label was detected diffusely in the epidermis, including
prominent staining in postmitotic suprabasilar cells (Fig 1b). Two
weeks after labeling, far fewer basal and suprabasilar cells showed
staining (Fig 1c), although strong staining was present in the bulge
region of hair follicles (Fig 1d). By 3±4 wk, epidermal staining was
detectable only in rare, scattered basal cells (Fig 1e). These data
con®rm that BrdU labeling was successful and that LRC were
present in the expected anatomical locations of epithelial stem cells.
Identi®cation of LRC by ¯ow cytometry Subsequently, we
evaluated if cells labeled with BrdU could be detected by using
¯ow cytometry. Immediately after labeling, 25%±40% of total
epidermal cells showed staining for BrdU compared to isotype
control by ¯ow cytometric analysis (Fig 2a, b). This labeling index
is consistent with the initial presence of labeled keratinocytes in the
basal keratinocyte population and not the suprabasal population of
epidermal suspensions (reported to contain 30% basal cells, 55%
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suprabasal cells, and 15% nonepithelial cells). The percentage of
labeled cells that we observe by FACS analysis also correlates well
with the histologic staining in the basal layer at time 0. Labeled cells
were predominantly small in size, as re¯ected by low forward and
side scatter, consistent with immunohistochemical staining showing
prominent staining along the basal layer. A marked separation in
¯uorescence intensity was apparent for labeled and unlabeled cells.
At 1 wk after labeling (Fig 2c), there was still a substantial labeled
population, which now included a greater proportion of larger
cells, probably representing suprabasilar cells that were labeled on
Figure 2. Flow cytometric analysis of
epidermal cells from labeled mice at various
time points after labeling. Suspensions of
epidermal cells stained with (a) isotype control
(FITC) or (b ±e)monoclonal antibody against
BrdU (FITC). Cells were isolated from mice (a, b)
immediately, (c) 7 d, (d) 19 d, or (e) 28 d after
in vivo labeling. Results are representative of at
least three experiments per time point.
Figure 1. Immunohistochemical analysis of
BrdU retention in keratinocytes at various
time points after labeling. Immunoperoxidase
staining for BrdU in ethanol-®xed mouse skin
sections (a) day 0, (b) 7 d, (c, d) 14 d, and (e) 28 d
after in vivo labeling. Arrows show (d) strong
staining in the bulge of the hair follicle at 14 d
and (e) scattered LRC present in the epidermis at
28 d after labeling. (a, b) 403; (c) 603; (d) 203;
(e) 803. Representative results from three
experiments shown.
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immunohistologic sections (Fig 1b). A continuum of ¯uorescence
intensity (less distinct separation) was observed because ongoing cell
division dilutes the BrdU label in daughter keratinocytes. By 19 d,
labeled cells constituted a still distinct population by FACS, making
up less than 10% of total cells (Fig 2d). At 4 wk an LRC
population of approximately 1%±3% of cells was consistently
detected (Fig 2e). The percentage of BrdU-labeled keratinocytes
we detected at both day 0 and day 28 is comparable to a previous
report of tritiated thymidine LRC detected in mouse truncal skin
by in situ autoradiography (Bickenbach et al, 1986).
Epidermis contains many cell types including Langerhans cells
and melanocytes. To demonstrate that LRC were predominantly
keratinocytes, we employed double-staining with a pan-cytokeratin
antibody. Of the total cell population, more than 80% of cells were
positive for keratin; among the LRC populations, more than 70%
were positive for keratin (data not shown). To assess the
completeness of keratinocyte isolation, dermal specimens remaining
after separation of epidermal sheets were analyzed by staining with
hematoxylin and eosin (Fig 3). There was no evidence of residual
interfollicular keratinocytes, and the cell suspension included the
majority of follicular epithelial cells. This indicates that follicular
keratinocytes, including LRC of the bulge region, were included in
our analysis.
Evaluation of cell-surface markers In order to ascertain if
BrdU positive LRC expressed known stem cell markers of other
tissues, the presence of CD34, Sca-1, and Flk-1 on LRC was
analyzed by double-staining. A representative cyto¯uorometric
analysis of cells double-stained with monoclonal antibodies directed
at CD34 and BrdU is shown in Fig 4(a)±(c). A small population of
cells retaining detectable BrdU is evident, but they do not exhibit
CD34 expression. Similarly, separate experiments revealed that
LRC populations do not express Sca-1 or Flk-1, respectively
(Fig 4d±i). This suggests that these stem cell markers are not
expressed on keratinocyte stem cells.
To ensure that the ®xation and DNA denaturing treatment
necessary to detect BrdU did not adversely affect the detection of
stem cell surface markers, ¯ow cytometric analysis of treated and
untreated cells was compared (data not shown). A similar pattern of
cell-surface expression was observed whether the cells were treated
or untreated, with the incidence of positive cells remaining
approximately the same (CD34 2.37% vs 2.16%; Sca-1 6.62% vs
6.21%; Flk-1 0.39% vs 0.50%).
FACS analysis was performed with monoclonal antibodies
directed against BrdU and b1 integrin to evaluate the relationship
between LRC and b1 expression. A spectrum of b1 integrin
expression was detected with LRC containing both high and low
levels of b1 expression (Fig 4j±l). These data con®rm that high
expression of b1 integrin is present on some LRC, but is not
speci®c for these cells (0.61% of cells are b1 integrin bright and
LRC+ 13.11% of cells are b1 integrin bright and LRC±).
DISCUSSION
Cutaneous gene therapy is a promising method of treatment for
genetic skin diseases and certain systemic diseases caused by the
de®ciency of a factor or enzyme (Gerrard et al, 1993; Hengge et al,
1995; Choate et al, 1996; White et al, 1998). Among the advantages
of targeting the skin are its accessibility for in vivo and ex vivo
manipulation, and the ease with which it can be monitored (Vogel
et al, 1996). Although attempts to introduce transgenes into the skin
have been successful, robust long-term expression remains elusive.
One approach to achieving this goal is to isolate and target stem
cells (Bickenbach and Roop, 1999). Increased ef®ciency of gene
transfer to these cells may result in long-term expression in a
signi®cant percentage of keratinocytes. Despite some success in
de®ning potential keratinocyte stem cell markers, more work needs
to be done to further characterize these cells.
Because label retention is thought to be one of the best methods
to identify epidermal and follicular stem cells, we investigated
potential cell-surface markers on LRC, which might serve as a
means of epidermal stem cell targeting. We evaluated CD34, Sca-1,
and Flk-1, known stem cell antigens that were ®rst described on
hematopoietic stem cells. CD34 is a saliomucin-like adhesion
molecule, found on 1%±3% of bone marrow cells as well as
endothelial cells, that has been used as a selection marker for
hematopoietic stem cells in mice and humans (Strauss et al, 1991).
Although CD34 negative hematopoietic stem cells have now been
described (Osawa et al, 1996; Goodell et al, 1997), enrichment of
CD34 positive bone marrow cells remains a highly utilized
technique in clinical gene therapy trials (Halene and Kohn,
2000). Sca-1 (Ly-6 A/E or stem cell antigen 1) is a phosphatidyl-
inositol-anchored protein of unknown function, but possibly an
adhesion molecule, commonly used for the puri®cation of murine
hematopoietic stem cells (Patterson et al, 2000). Flk-1 is the mouse
homolog of the human vascular endothelial growth factor receptor
2 (VEGFR2 or KDR), a recently described marker for purifying
hematopoietic stem cells, in conjunction with CD34 (Ziegler et al,
1999). These markers were chosen because skeletal muscle stem
cells have been reported to share one or all of these markers (see
above), raising the possibility that other tissue stem cells may also
possess these markers (Gussoni et al, 1999; Jackson et al, 1999; Lee et
al, 2000).
In this study we were able to consistently ®nd a small population
of slowly cycling cells that retained BrdU label at 3±4 wk. These
LRC were primarily keratinocytes, as more than 70% stained with a
pan-cytokeratin antibody. Flow cytometry indicated that LRC were
predominantly small sized, as has been previously demonstrated
using density gradient sedimentation (Morris et al, 1990; Tani et al,
2000). Using two-color ¯ow cytometry we did not ®nd cell-surface
CD34, Sca-1, and Flk-1 expression in LRC. Therefore, our data do
not support that these markers are expressed on epidermal stem cells.
As we de®ne stem cells by the property of long-term label retention,
however, we cannot exclude the possibility that non-label-retaining
keratinocytes containing the markers CD34, Sca-1, or Flk-1
represent important progenitor cells.
Previously, a 2-fold increase in b1 integrin levels in cells with
high colony forming ef®ciency has been reported (Jones and Watt,
1993), and we evaluated its expression on LRC. b1 integrin is
found on all basal cells and, as expected, a spectrum of expression
on cells in an epidermal cell suspension was observed by ¯ow
cytometry. Speci®city of high expression was not seen for LRC,
however.
Although CD34, Sca-1, and Flk-1 were felt to be the most likely
candidate markers for epidermal stem cells, it is possible that other
markers will be described that are shared on stem cells from many
organ systems, including the skin. In addition to cell-surface
markers, other common characteristics such as ef¯ux of vital dye
may be shared between epidermal stem cells and other types of stem
cells. As our understanding of stem cell plasticity increases and
investigations are carried out to determine if, like neural,
hematopoietic, and skeletal muscle stem cells, epidermal stem
Figure 3. Histology of skin following separation of epidermal
sheet. Hematoxylin and eosin staining of the dermis (203) shows no
remaining basal cells and few residual follicular keratinocytes, indicating
these cells were included in the epidermal suspension.
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cells are capable of multipotential differentiation, the likelihood of
®nding shared and even universal stem cell features should be better
determined.
We acknowledge Dr. Mark Udey and others of the Dermatology Branch of the
National Cancer Institute for their helpful comments and discussion.
Figure 4. Flow cytometric analysis of cells double stained for BrdU and stem cell markers. Epidermal cells were stained with monoclonal
antibody against BrdU and stem cell markers along with appropriate isotype controls. Staining is shown for (a±c) BrdU (PE) and CD34 (FITC), (d±f)
BrdU (PE) and Sca-1(FITC), (g±i) BrdU (FITC) and Flk-1 (PE), and (j±l) BrdU (PE) and b1 integrin (FITC). Cells were isolated from mice (a±c, g±l)
21 d and (d±f) 24 d after labeling. Results are representative of at least three experiments per cell-surface marker tested.
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